Gas-phase structural characterization of neuropeptides Y Y1 receptor antagonists using mass spectrometry: Orbitrap vs triple quadrupole

J Pharm Biomed Anal. 2018 Mar 20:151:227-234. doi: 10.1016/j.jpba.2018.01.013. Epub 2018 Jan 9.

Abstract

Collision induced dissociation of triple quadrupole mass spectrometer (CID-QqQ) and high-energy collision dissociation (HCD) of Orbitrap were compared for four neuropeptides Y Y1 (NPY Y1) receptor antagonists and showed similar qualitative fragmentation and structural information. Orbitrap high resolution and high mass accuracy HCD fragmentation spectra allowed unambiguous identification of product ions in the range 0.04-4.25 ppm. Orbitrap mass spectrometry showed abundant analyte-specific product ions also observed on CID-QqQ. These results show the suitability of these product ions for use in quantitative analysis by MRM mode. In addition, it was found that all compounds could be determined at levels >1 μg L-1 using the QqQ instrument and that the detection limits for this analyzer ranged from 0.02 to 0.6 μg L-1. Overall, the results obtained from experiments acquired in QqQ show a good agreement with those acquired from the Orbitrap instrument allowing the use of this relatively inexpensive technique (QqQ) for accurate quantification of these compounds in clinical and academic applications.

Keywords: Antagonist; Diabetes; Mass spectrometry; Obesity; Orbitrap; Triple quadrupole.

Publication types

  • Comparative Study

MeSH terms

  • Arginine / analogs & derivatives*
  • Arginine / analysis
  • Arginine / chemistry
  • Limit of Detection
  • Receptors, Neuropeptide Y / antagonists & inhibitors*
  • Tandem Mass Spectrometry / economics
  • Tandem Mass Spectrometry / instrumentation
  • Tandem Mass Spectrometry / methods*

Substances

  • BIBP 3226
  • Receptors, Neuropeptide Y
  • neuropeptide Y-Y1 receptor
  • Arginine
  • BIBO 3304